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The Cystic Fibrosis (CF) lung harbors a complex, polymicrobial ecosystem, in which Pseudomonas
aeruginosa is capable of sustaining chronic infections, which are highly resistant to multiple antibiotics.
Here, we investigate the phenotypic and genotypic diversity of 44 morphologically identical P. aeruginosa
isolates taken from a single CF patient sputum sample. Comprehensive phenotypic analysis of isolates
revealed large variances and trade-offs in growth, virulence factors and quorum sensing (QS) signals. Whole
genome analysis of 22 isolates revealed high levels of intra-isolate diversity ranging from 5 to 64 SNPs and
that recombination and not spontaneous mutation was the dominant driver of diversity in this population.
Furthermore, phenotypic differences between isolates were not linked to mutations in known genes but were
statistically associated with distinct recombination events. We also assessed antibiotic susceptibility of all
isolates. Resistance to antibiotics significantly increased when multiple isolates were mixed together. Our
results highlight the significant role of recombination in generating phenotypic and genetic diversification
during in vivo chronic CF infection. We also discuss (i) how these findings could influence how
patient-to-patient transmission studies are performed using whole genome sequencing, and (ii) the need to
refine antibiotic susceptibility testing in sputum samples taken from patients with CF.
T
he Cystic Fibrosis (CF) lung presents a complex polymicrobial ecology, which in turn complicates the
treatment of chronic bacterial respiratory infection. The pathogen most commonly associated with CF is
Pseudomonas aeruginosa. Ubiquitous in the environment, P. aeruginosa is one of the leading causes of
opportunistic infections in humans1, and is a major cause of increased morbidity and mortality in patients
with CF2. Its ability to colonise pulmonary epithelial cells, communicate using quorum sensing (QS) signals
and form multicellular biofilms, plus its innate resistance to many antimicrobials, results in chronic infec-
tions that are almost impossible to eradicate, leading to a clinical pattern of intermittent exacerbations and an
eventual decline in lung function2–4. Furthermore, initial colonising strains of P. aeruginosa, thought to be
acquired from the environment, have the potential to be displaced by more virulent and transmissible
epidemic strains5–7.
It is now well established that founder P. aeruginosa populations evolve over many years of chronic CF
infection, leading to high levels of temporal phenotypic and genetic diversity within a single patient5,8–15.
Longitudinal genomic studies of single colonies isolated from individual CF patients suggest such variation is
derived from a mixture of single base pair mutations, insertion and deletion events and recombination events10,16.
Additionally, recent studies have examined the diversity of P. aeruginosa populations isolated from individual
patients at a single time point14. These suggest that considerable phenotypic variation exists at any given time and
Pulsed-Field Gel Electrophoresis (PFGE) is suggestive of some level of genetic variation14. Despite these studies, it
is still not clear how such diversity arises and how this impacts on clinically important factors such as identifying
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Recent studies examining diversity within P. aeruginosa popula-
tions isolated from the CF lung have described significant variation
in antibiotic susceptibility profiles in isolates which vary in morpho-
logical appearance. The most commonly described difference is that
observed between mucoid and non-mucoid colonies2,9,17. However,
no study has conducted a detailed examination of a single, morpho-
logically homogeneous population of P. aeruginosa, nor has any
study provided a comprehensive map at the genome level of pheno-
typic variation within an extant CF lung population.
Here we address this gap in our understanding of how diversity
evolves in the CF lung and how this may impact on decisions made in
a clinical setting, where microbiological analyses are often based on a
single colony. We have comprehensively analyzed the levels of
phenotypic and genotypic diversity within a single CF lung ecosys-
tem at a single snapshot in time. We reveal previously unobserved
correlations and trade-offs between the production of different viru-
lence-related exoproducts, quorum sensing (QS) signals and resis-
tances to a range of clinically-relevant antibiotics. Furthermore, we
show significant increases in antibiotic resistance when multiple
isolates are cultured together. Finally, we use a range of genomic
analyses to quantify genotypic diversity within this single patient.
These reveal (i) the dominant role of recombination over spontan-
eous mutation in the generation of in vivo diversity; (ii) unexpected
and complex relationships between genotype and phenotype; (iii) the
difficulty of classifying patient-to-patient transmission events based
on the analysis of single colonies; and (iv) the likely underestimation
of antibiotic resistance based on testing a single or few colonies per
patient.
Results
P. aeruginosa isolates from a single sputum sample display phe-
notypic tradeoffs. We randomly selected 44 morphologically
identical, non-mucoid P. aeruginosa colonies (hereafter referred to
as isolates) from a single spontaneously expectorated sputum sample
from a clinically stable CF patient with a chronic P. aeruginosa in-
fection. We assayed each isolate for overnight growth in standard
laboratory medium and for a selection of phenotypes that have
previously been associated with virulence in CF infection. The
isolates displayed considerable variation in growth and also in the
production of tissue-degrading proteases (LasA protease and LasB
elastase), the redox-active toxin pyocyanin and the QS signal
molecules N-butyryl-L-homoserine lactone (C4-HSL), N-(3-
oxododecanoyl)-L-homoserine lactone (3O-C12-HSL), 2-heptyl-3-
hydroxy-4(1H)-quinolone (PQS), 2-heptyl-4-hydroxyquinoline N-
oxide (HQNO) and 2-heptyl-4-quinolone (HHQ). These data are
summarised in Fig. 1a and b.
We then wished to determine the extent to which the expression of
different virulence factors covaried. On the one hand, the variation
shown in Fig. 1a and b could reflect a set of isolates with phenotypes
that range from generally low virulence (poor growth and low levels
of virulence factor expression) to generally high virulence (extensive
growth and high levels of virulence factor expression). On the other
hand, the isolates could have qualitatively different phenotypes – e.g.
some may produce lots of protease but very little pyocyanin, while
others may show the opposite pattern, suggesting that expression of
one phenotype could be traded off against another. To address this
question, we conducted principal component analyses (PCA).
The results of a PCA on growth and three virulence-associated
exoproducts (LasA, LasB and pyocyanin) are shown in Fig. 1c. This
revealed negative correlations between the traits, such that no indi-
vidual isolate demonstrated high values for all four variables. In
particular, higher growth was associated with lower per-cell produc-
tion of LasA protease and LasB elastase, whilst higher pyocyanin
production entailed lower LasA protease production: these relation-
ships are illustrated by the vectors for the original variables pointing
away from each other on the PCA plot. The first two principal com-
ponents explained approximately 70% of the total variation in these
phenotypes. Pairwise Spearman’s rank correlations produced results
consistent with the PCA and the results for phenotype-related traits
were unchanged by the exclusion of one outlier (SED23)
(Supplementary Fig. S1).
We conducted a separate PCA on the production of five key QS
signals, which between them regulate the expression of a range of
virulence factors. QS signals have previously been extracted from the
sputum of CF patients18,19. Production levels of the five molecules
were generally positively correlated, reflected by the close alignment
of the vectors representing the original variables on the PCA plot
(Fig. 1d). The first two principal components account for almost 90%
of the total variation in the data set and the majority of the data points
varied mainly in their level of 3O-C12-HSL production. Consistent
with the PCA results, pairwise Spearman’s rank correlation coeffi-
cients (Supplementary Fig. S1) revealed an almost perfect correlation
between HQNO and PQS production (rs 5 0.96, p , 0.001), both of
which were also strongly correlated with the production of C4-HSL
(rs 5 0.89 and 0.85 respectively, p , 0.001) (Supplementary Fig. S1).
Whole genome SNP typing shows high levels of diversity and
signatures of adaptive events in the extant P. aeruginosa popula-
tion. To contextualize the high levels of phenotypic diversity
observed within this single sputum sample, we performed whole
genome sequencing on 22 of the 44 isolates (SED 1–22), which
were selected to represent the full spectrum of phenotypic
diversity. Both methods confirmed that all isolates were close
relatives of the Liverpool Epidemic Strain (LESB58), a particularly
aggressive epidemic clone of P. aeruginosa20. As such, we performed
mapping of raw sequence data for all 22 variants against the LESB58
reference genome using SNP calling parameters equivalent to those
used in recent genomic epidemiological studies of microbial
infection21,22. The resulting phylogeny (Fig. 2) and SNP distance
matrix (Supplementary Fig. S2) confirmed that the patient was
initially infected with a clone very similar to LESB58, which then
most probably diversified within the lung, resulting in considerable
levels of intra-population diversity. There were a total of 121 high-
resolution SNPs called across the population, with 24 of those
present across all isolates compared to the reference and so
considered ancestral variants. None of the 22 isolates had a SNP
difference range within 5 SNPs of the LESB58 reference strain and
the most extreme differed by 64 SNPs (Supplementary Fig. S2 and
Supplementary Table S1). Of the 77 SNPs which varied across the
isolates, 45 were present in multiple isolates randomly distributed
across the phylogeny (Table 1).
Despite all of these variants originating from the same single
founder clone, such dissemination of SNPs is reminiscent of homo-
plasic mutation, where mutations in the same nucleotide occur inde-
pendently in phylogenetically distinct individuals. A number of the
homoplasic-like sites also appeared to be under the force of positive
selection as determined by dN/dS ratios. This indicated that non-
synonymous mutations in mexB, PLES_11151, PLES_28341, glyA2,
and PLES_59241 all displayed signatures of adaptive evolution in this
extant population with dN/dS ratios far in excess of 1. Attempts to
superimpose the observed phenotypic diversity of the 22 isolates
onto the phylogeny failed to show any pattern of acquisition or
accrual of phenotypes along the evolutionary trajectory of the phylo-
geny, with phenotypes appearing randomly across the tree (Fig. 2).
This is consistent with our observations of homoplasic-like accrual of
mutations which can occur as a result either of fixation of selectively
advantageous mutations, or by intra-population recombination.
None of the high stringency SNPs identified in the mapping process
showed a meaningful biological correlation with the phenotypic
diversity. The vast majority of isolate-unique SNPs occurred in
SED8, however this isolate showed no mutations associated with
hypermutation (nor did any other isolate) and all isolates failed to
www.nature.com/scientificreports
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display classical hypermutation phenotypes when analysed using
standard rifampicin spontaneous resistance testing (data not
shown).
Analysis of de novo assembled genomes indicates a dominant role
for recombination in generating diversity in the extant popu-
lation. Whilst high resolution SNP typing gives the most accurate
determination of variation within the population, it does not take
into account large-scale insertion, deletion, and chromosomal
rearrangement events which may generate diversity. Corrected de
novo genome assemblies were constructed for each isolate using
Velvet and PAGIT, and from these, whole genome alignments
were performed using progressiveMauve and pairwise Blast
comparisons using Blast Ring Image Generator (BRIG). Both
comparative methods showed a lack of large-scale insertion or
deletion events responsible for the phenotypic diversity. The loss
of a 26.4 Kbp cryptic phage in isolates SED2, SED11 and SED19
compared to LESB58 is the most obvious region of difference
(Supplemental Fig. S3). However this event shows no correlation
to any phenotypic pattern seen in these isolates. Perhaps more
significantly, there are no acquisition events in any of the 22 vari-
ants sequenced as determined by a Progressive Mauve alignment of
the de novo assembled sequences (Fig. 3). Given that large-scale
acquisitions and deletions are well documented in longitudinal CF
P. aeruginosa populations, we further confirmed our finding by
constructing a pan-genome of the de novo assembled genomes,
our 22 variants and LESB58, and plotted the presence and absence
of every locus as a heat map (Supplemental Fig. S4). Our data clearly
shows there are no large genomic islands that have been acquired by
any of the variants. There are a small number of genetic loci which
appear to be strain specific, however BLAST analysis identified these
as genes with highly divergent sequences compared to the ortholog in
LESB58.
We also checked for major chromosomal inversions and rearran-
gements which may confer intra-population diversity by utilising our
paired-end sequencing reads and performing break-point analysis
on each de novo assembly compared to the reference LESB58 gen-
ome (Supplemental Fig. S5). Our analysis suggests the presence of
Figure 1 | Phenotypic diversity of P. aeruginosa populations. We measured growth, exoproducts and QS signal molecules of individual isolates and
expressed these as a percentage of the values obtained for a PAO1 wildtype. Each data point represents the mean of triplicate assays for an individual isolate.
(A) Phenotypic assays for growth and exoproduct production show that isolates display large variation between individuals when compared with the PAO1
reference strain. (B) QS Signal molecule measurements show that variation occurs between isolates when compared to the PAO1 reference strain. Panels
(C) and (D) show the results of PCA on phenotypic and QS signal data respectively. PCA reduces multiple variables (four phenotypic traits or five QS
molecules) to two dimensions, allowing us to plot multivariate data on simple x,y coordinates. The arrows are vectors that show how the original variables
relate to the new x and y axes. The PCA plots show that QS signals are linked and that tradeoffs exist between other phenotypes measured.
www.nature.com/scientificreports
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just a single observable inversion event in isolate SED5 with the
genomic architecture across all 22 variants almost identical by our
analysis. Finally we checked for subtle differences, which may result
in frameshift mutations. Our previous SNP analysis identified just
one mutation in the mexB gene present in 2 variants, which intro-
duced a premature stop codon, and two SNPs affecting intergenic
regions possibly affecting gene expression. To confirm there were no
small indel events causing frame shifts, we systematically compared
each of the 22 variant genomes against LESB58 using Artemis
Comparison Tool (ACT) looking for truncated ORFs or CDS mer-
gers, as well as indels in intergenic regions in the variants, however no
such frameshift mutations were found in the data set.
Given the identification of a number of regions with highly diver-
gent sequence in the variants compared to LESB58, and the earlier
identification of homoplasic-like mutations randomly distributed
across the population phylogeny, we determined the levels of recom-
bination in the de novo assembled genomes. BRATNextGen analysis
on a core genome alignment detected recombination events in all
genomes ranging from a single event in SED19 to seven recombina-
tion segments in SED18 (Supplemental Fig. S6), with almost all
detected recombinant segments shared across some members of
the data set, indicative of intra-population recombination. From
the alignment of corrected genome assemblies, there were a total of
1436 single nucleotide polymorphisms (SNPs) across the 22 gen-
omes, with 1296 present in regions identified as recombining, giving
an r/m value of 9.2571. This indicates that the SED isolates are
approximately ten times more likely to have acquired genetic vari-
ation by recombination than by spontaneous mutation. More impor-
tantly of the 45 high resolution SNPs exhibiting homoplasic-like
properties, 40 were located on recombining regions, supporting the
likelihood that mutations are being propagated across the extant
population by recombination.
Phenotypic diversity in the extant P. aeruginosa population does
not associate with previously reported and associated mutations.
As mentioned previously, attempts to superimpose the observed
phenotypic diversity of the 22 isolates onto the phylogeny failed to
show any pattern of acquisition or accrual of phenotypes with
variable phenotypes appearing randomly across the tree (Fig. 2),
which is consistent with dissemination via recombination. None of
the high stringency SNPs identified in the mapping process showed a
correlation with the phenotypic diversity we observed as reported in
classical bacterial genetics experiments. Given our observation of
significant intra-population recombination, we investigated if there
was a statistical correlation between recombination events and
phenotypic diversity. We utilised the widely accepted technique of
performing permutation tests of phenotypes against the whole geno-
me alignments23 and identified between 5 (LasA production) and 15
(HHQ production) recombining regions significantly associated
(p , 0.05) with variation observed in a given phenotype (Fig. 4;
Supplementary Table S2), including regions enriched for homo-
plasic mutations in the high-confidence SNP typing data (Table 1).
Each of these recombining regions was mapped onto the LESB58
reference genome, allowing us to identify the CDS present in each
region (Fig. 4). This analysis showed a high degree of overlap in the
recombining regions associated with different phenotypic changes.
Of particular interest are the recombining loci significantly assoc-
iated with altered levels of production of PQS and HQNO which are
completely identical (Supplementary Table S2), suggesting these two
phenotypes are intrinsically linked. This observation matches our
phenotypic observation that PQS and HQNO production are almost
perfectly correlated (Fig. 1d and Supplementary Fig. S1). Though a
small number of recombining loci are associated with a change in just
one phenotype, a total of 19 recombining CDS are significantly
associated with an alteration in 2 or more observed phenotypes. Of
Figure 2 | Maximum likelihood phylogeny based on SNP typing of the 22 sequenced isolates against LESB58. Nodes obtaining .95% bootstrap support
(black circles) and .75% bootstrap support (grey) are indicated on the tree. The heatmaps accompanying each taxa represent the levels of production of
each phenotype relative to the reference PAO1 strain and are indicated above SED21. Abbreviations: G (growth), LasA (LasA protease), LasB (protease),
Pyo (pyocyanin), C4 (C4-HSL), 3O (3O-C12-HSL).
www.nature.com/scientificreports
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equal importance is that none of the loci have been associated with
such phenotypic properties by way of classical bacterial genetics and
mutagenesis studies.
Phenotypic and genetic diversity results in variation in antibiotic
susceptibility between isolates. Previous studies have shown that
there is little correlation between antibiotic sensitivity patterns of
P. aeruginosa isolated during a pulmonary exacerbation and the
subsequent clinical response of the patient24,25 and reproducibility
of the diagnostic test itself has been shown to be low between sample
replicates26,27. We determined the resistance of our 44 isolates to 9
commonly used CF therapeutic agents using the BSAC disk diffusion
method. We noted large variances in susceptibility between isolates
according to the zone of inhibition produced (Fig. 5a). Pairwise
correlation analysis revealed several significant positive correla-
tions indicating the tendency for some isolates to have relatively
high resistance to multiple antibiotics whilst others had relatively
low resistance to multiple antibiotics (Supplementary Fig. S7).
Correlations in resistance were also found between antibiotics with
similar mechanisms of action (such as the aminoglycosides).
We then mixed all 44 isolates as a population for comparison with
individual isolates and repeated the antibiotic susceptibility testing.
We found that variation in the zone of inhibition was reduced in
mixed versus single isolates, indicating that picking colonies at ran-
dom and mixing them together as a population gives a more con-
sistent antibiotic resistant phenotype (Fig. 5b and Supplementary
Fig. S8). Furthermore, we found that mixing all 44 isolates together
resulted in a level of antibiotic resistance that was higher than the
mean of the individual isolates tested (t17,450 5 22.208, p 5 0.028),
indicating that testing at the individual isolate level may underestim-
ate resistance (Fig. 5b). The complexity of the antibiotic resistance
variation observed across all our isolates meant that any attempts to
significantly associate recombination events to specific changes in
resistance patterns proved unsuccessful. This is almost certainly due
to the restricted size of our data set, with recent GWAS studies
mapping specific recombination and mutation events to changes
in susceptibility profiles requiring thousands of isolates to achieve
statistical significance28,29.
Discussion
A number of recent studies have shown extensive phenotypic vari-
ation between different P. aeruginosa CF strains and isolates of the
same strain taken from single patients5,8,9,11,12,14,30,31. Despite all these
studies, the reasons for this phenotypic diversity remain poorly
Table 1 | Homoplasic SNPs involved in adaptive evolution
SNP position CDS Mutation No. Haplotypes with mutation dN/dS
468009 mexB Stop codon 2 10.658
1211690 PLES_11151 – Carboxyl esterase Val to Ala 2 9.99









1469485 PLES_13631 – hypothetical protein synonymous 19 0.008




1658081 PLES_15261 – NADH quinone reductase Glu to Ala 3 1.023
1676171 PLES_15441 – mechanosensitive ion channel Val to Ala 2 1.063
1986123 PLES_18391 – ATP binding permease Synonymous 2 0.001
2690373 tRNA-Ser NA 7
2690375 NA 5
3020931 mexT Val to Ala 2 1.032
3048652 PLES_28331 – putative haemoylsin secretion/activation protein synonymous 19 0.009
3048751 synonymous 17
3058594 PLES28341 – hypothetical protein Gly to Ala 9 11.478
3058611 Ala to Thr 5
3090543 glyA2 Leu to Iso 16 6.06
3090547 Glu to Arg 11
3090548 Glu to His 8
3090609 Iso to Leu 4
3378695 psiK Synonymous 2 0.001
3378321 pslJ synonymous 7 0.002
3478510 PLES_31551 - hypothetical Leu to Phe 2 1.098
3502354 PLES_31741 – trehalose synthase Leu to Val 2 1.049
3973880 Intergenic PLES_35761 - cysB NA 5
4015334 pcrV Asp to Asn 2 1.104
4026225 pscT Asn to Lys 4 1.088
4539068 PLES_41121 – NAD deacetylase Val to Ala 4 1.099
5133783 Intergenic PLES_46606 - sbcD NA 7
5172963 pctC Leu to Pro 5 1.008
6430173 glyA1 Glu to Arg 16 0.305
6430175 synonymous 19
6557923 PLES_59241 – hypothetical protein Ala to Gly 14 3.227
www.nature.com/scientificreports
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Figure 3 | Whole genome alignments of the de novo assembled genomes of 22 isolates and the reference genome LESB58. Alignment was constructed
using Progressive Mauve, and local collinear blocks containing orthologous sequence are colour coded.
www.nature.com/scientificreports
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understood. In addition, there is little to no information available
about whole genome resolution of the extant diversity of P. aerugi-
nosa within a CF lung at any given time point. Here we show that P.
aeruginosa intra-host diversification is strongly linked to recombina-
tion. Our findings have broad implications for (i) classical pheno-
type/genotype correlations; (ii) informing contact transmission
networks and (iii) routine antibiotic susceptibility testing.
We began our study by taking 44 morphologically identical non-
mucoid ‘isolates’ from a single sputum sample, obtained from a
patient with CF, known to be chronically infected with P. aeruginosa
for approximately 3 years. At the time of sampling the patient was
clinically stable and was prescribed standard maintenance oral and
nebulised therapies only. Although all of the isolates appeared mor-
phologically indistinguishable on agar plates, with no small colony
variants, they actually displayed extensive phenotypic variation
when screened for growth, pyocyanin, LasA and LasB production
and QS signal molecule production. This is in broad agreement with
other recently published work. For example, it has been reported that
the majority of phenotypic diversity occurs within patients rather
than between patients9 and that identical colony morphotypes from a
given patient demonstrate a large degree of phenotypic variation14.
We used our phenotypic data set to determine whether there were
correlations between (i) phenotypes and (ii) QS signal molecules.
Extensive molecular studies over the past 20 years have shown that
particular traits are linked by complex genetic networks. For
example, the production of different QS signals have been shown
to be linked, whilst QS links key phenotypes such as LasB (elastase)
and pyocyanin32,33. The majority of these studies have been under-
Figure 4 | Circular representation of regions identified as undergoing recombination relative to the LESB58 reference genome. Regions statistically
associated with phenotypes are indicated in the concentric ring representing that phenotype (Growth innermost to HQNO outermost). The ORFs
encoded in recombining regions are indicated by their gene name as annotated in LESB58. The Gene name-tags are colour coded to indicate clearly the
phenotypes they are associated with.
www.nature.com/scientificreports
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taken using the laboratory standard P. aeruginosa strain PAO1, a
wound isolate taken during the 1950’s34. Using PCA we found pos-
itive correlations between five key QS signal molecules produced by
P. aeruginosa, with particularly strong correlations between PQS and
HQNO and PQS and C4-HSL. These positive correlations broadly fit
with what has been described in the literature for PAO1. In contrast
we found trade offs between the other phenotypes tested (growth,
LasA, LasB & pyocyanin). For example, increased growth resulted in
a reduced per cell production of both LasB and LasA (Fig. 1). Our
results demonstrate that phenotypic correlations found in well-
studied laboratory wild types of P. aeruginosa do not necessarily
match in P. aeruginosa strains recently collected from in vivo infec-
tions. The reasons for these trade-offs are unknown, but a number of
factors, such as within-host competition, lung spatial structure, host
immune response, transmission events and host survival, could
produce evolutionary trade-offs between phenotype and parasite
virulence35,36.
We attempted to contextualize our phenotypic observations by
performing genome sequencing on 22 isolates, which were chosen
to represent the full spectrum of diversity observed. Examination of
differences in gene content showed there were no gene acquisition or
loss events across our isolate set. A small cryptic prophage had
excised from three of the isolates but this does not correlate with
any particular phenotypic pattern. Previous studies examining the
diversity of LES strains from across the globe have shown far greater
variation in gene content between strains with variation in large
genomic islands37,38. In contrast a study of 55 isolates from 21 indi-
viduals showed no large scale insertions or deletions, as well as the
presence of parallel patho-adaptive mutations39. PFGE based studies
examining extant diversity in patients has shown variations in geno-
mic architecture40. Similarly frameshifts and small indels have prev-
iously been reported to be key in generating phenotypic diversity
within clonal P. aeruginosa populations41, but such genetic variation
was not detected in our data set. Conversely a recent study, which
investigated the experimental evolution of a P. aeruginosa popu-
lation over time42, showed very few indels fix within a population
over time, and that small indels resulting in frameshift mutations
came under extremely strong purifying selection.
Our SNP phylogeny showed a total of 121 variable sites with
respect to the LESB58 reference genome, 24 of which were common
and so considered ancestral to the original infecting strain. This
leaves a total of 97 differentiating SNPs in our set of variant strains.
Such levels of diversity within a patient infected for 3 years seem high
when one considers a recent genomic study of P. aeruginosa strain
PA14, which reported an accumulation of only 15 SNPs over a period
of 15 years43, and a study of global and temporally distributed LES
strains which reported a distance range of 66–156 SNPs37. However
our observed levels of extant diversity are not unreasonable if one
considers the mutation levels calculated for S. aureus of 1 core gen-
ome SNP every 6 weeks44 which would equate to an expectation that
any random isolate variant would differ from its ancestor by approxi-
mately 27 SNPs after the 3 year period in which the lung has been
infected. This is within the magnitude of values obtained between
any pair of isolates in our pairwise SNP distance matrix with the
exception of SED8. The possibility also exists that the differences
in SNP levels between our study and those conducted in PA14 reflect
the differences in mutation accumulation occurring during the initial
stages of adaptation compared to those occurring in an established
infection where the infecting strain is well adapted to the lung
environment.
The SNPs observed at 45 of the reference genome variant sites
exhibited characteristics of homoplasy. A number of the homoplasic-
like sites also displayed dN/dS ratios far in excess of 1, which is a
strong signal for positive selection, suggesting these sites are under-
going adaptive evolution. Our data showing multiple homoplasic-
like sites under neutral selection in combination with defined sites
under adaptive evolution mirrors that recently shown in a compre-
hensive study of within patient diversity of Burkholderia dolosa
within the CF lung45. The B. dolosa study was performed on multiple
isolates accumulated from multiple patients over time and provided a
definitive blueprint for pathogen evolution in the CF lung. Our study
expands on this by examining extant isolates of a far more prevalent
CF pathogen, P. aeruginosa, in a single patient, and provides further
evidence for the forces underpinning the generation of diversity in a
pathogen population in the CF lung. The vast majority of our iden-
tified SNPs occurred in hypothetical proteins as opposed to surface
associated factors45 or drug resistance associated loci44.
Our finding that the vast majority of SNPs within our isolate data
set are present in regions undergoing recombination also provides
further resolution to the mechanisms by which diversity may be
generated within the CF lung. It has long been known that genetic
recombination occurs in P. aeruginosa34, and our data suggests that
recombination is an important factor in the short-term generation of
Figure 5 | Antibiotic resistance profiles for 44 isolates measured using
the BSAC method. (A) The antibiotic susceptibility of single isolates to
common CF therapeutics. The recorded zones of inhibition and mean
value for each 44 individual isolates are shown. Each data point represents
the mean of three independent biological replicates for each individual
isolate. (B) Resistance profiles of each individual isolate to 9 antibiotics
compared to a mixed community of all 44 isolates. Each blue point
represents the sensitivity profile of a single isolate and red points represent
7 independent measurements of a mixed community containing all 44
isolates. In both (A) and (B), the values for individual clones represent the
mean of three independent biological replicates. Individual clones
consistently underestimate the resistance of the mixed community.
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genetic diversity within P. aeruginosa isolates within the CF lung
with an r/m rate approaching 10. Homologous recombination has
been shown to play an important role in the early adaptation of P.
aeruginosa to the human lung, principally in creating deletions lead-
ing to genome reduction16. That particular study focused on a col-
lection of isolates from multiple patients spanning a 35-year period
whereas our study focuses on the diversity sampled at a single time
point, and therefore our data suggests for the first time, that recom-
bination is extremely important in the continuous evolution of P.
aeruginosa within individual patients with CF.
Instances of large scale acquisitions, indels, frame shifts, and chro-
mosomal inversions affecting P. aeruginosa phenotypes undoubtedly
exist over temporal and geographical scales, as do accumulation of
adaptive mutations. However our data, and that from experimentally
evolved populations, may suggest that such events occur as a result of
enormous selection pressures exerted within fluctuating environ-
ments over time, and may be less commonplace in stable populations
or in short term evolutionary events. Whilst it cannot be excluded
that our observations are highly specific to the strain and/or patient
environment we have studied, it must be noted that the populations
examined are very different. Our extant diversity study highlights the
levels of diversity present in a lung at any given time point. Temporal
studies are more likely to identify dominant genotypes within a
patient at each time point sampled, therefore identifying long term
selective evolutionary events. This is even more likely if sequencing is
performed on a sweep of colonies from a growth culture. As such it is
possible our data set may identify loci which arise under short term
evolutionary pressures as opposed to the longer term evolutionary
forces exposed in temporal studies. Recent work examining the
evolution of Salmonella paratyphi, suggested that the vast majority
of mutations which occur in that pathogen population are transient,
coming under positive selective pressure for a limited time-frame
before being purged by negative selection due to the detrimental
effect on metabolic fitness46. Our findings suggest that future studies
that aim to analyse how a strain evolves within patients by repeatedly
sampling patients over time, should consider taking multiple col-
onies or populations per patient at each time point to better under-
stand how the evolutionary forces currently known to impact
pathogen evolution relate to the levels of extant diversity at each time
point and how these two interplay. This would provide even greater
resolution into how pathogen populations evolve in response to the
human host.
The majority of our high-quality SNPs mapped against hypothet-
ical proteins and none of them mapped against genes which would
normally be associated with the phenotypic changes observed in our
isolates. For example, the phenotypes we measured (LasA, LasB and
pyocyanin) have all been shown to be highly QS-dependent32,33.
Furthermore, lasR mutants have been shown to accumulate in the
CF lung10. Despite this, none of our SNPs mapped against any known
genes thought be involved in QS. When we performed statistical
correlations between recombining regions and observed phenotypes,
we also found regions significantly associated with phenotypic vari-
ation in genetic loci not classically associated with such phenotypes.
Our data set highlights the intricate complexity of genetic mutations
and their knock on effects on microbial phenotypes. It also suggests
that whilst classical bacterial genetic experiments accurately identify
loci involved in colonization, persistence and virulence in culture and
in model systems, the mutations that underlie phenotypic alteration
and adaptation to the human environment may be far more subtle
and likely involve genetic loci whose function we do not yet fully
understand. Very recent work in Salmonella typhimurium has
demonstrated that bi-stable expression of virulence factors within
an infecting population leads to the formation of other beneficial
phenotypic changes in sub-populations, in that instance resistance
to antimicrobials47. It was also shown that bet-hedging of heterogen-
eous expression of virulence factors in a population can protect
clonal populations against mutants which subvert labour division.
This draws comparisons to our observations in that bet-hedging and
labour division can arise through trait variations and subsequent
complex interactions between them, exposing degrees of functional
complexity of phenotypic variation previously unreported.
Our study also has implications for understanding infection trans-
mission networks. Our SNP distance matrix shows that the patient
was likely infected with a clone very similar to LESB58 and that this
has diversified in the lung via recombination. This has a potential
impact on how to accurately inform contact transmission networks,
with many published studies using whole genome sequencing
(WGS) to inform outbreak transmission events using a cut-off of
,5 SNPs48, or in the exemplar case of MRSA, 11 SNPs21. Our data
suggests that baseline levels of within-patient diversity for pathogens,
infectious disease and transmission scenarios may need to be
developed for meaningful WGS transmission studies. Otherwise
multiple colonies or whole populations may need to be sequenced
from every sample during transmission studies, to prevent transmis-
sion events from being misclassified.
Finally our work has implications for antibiotic testing. Suscepti-
bility testing of bacterial isolates to antibiotics plays an important
role within the diagnostic laboratory and helps to guide antibiotic
choice for the treating clinician, and high levels of P. aeruginosa
diversity within a patient has potential implications for routine anti-
biotic susceptibility testing. The validity of susceptibility testing has
been challenged by several studies. Hogardt and colleagues demon-
strated susceptibility results ‘‘close to random’’ when testing quino-
lones and tobramycin resistance in a selection of P. aeruginosa CF
isolates49, whilst a study conducted in 1994 by Morlin compared
individual morphotypes and mixed morphotypes, finding that when
predicting resistance to a panel of antibiotics, the assay was far less
accurate50. In the U.K., the current standard laboratory protocol for
the testing of CF sputa relies on the selection of 1 or 2 colonies of
different morphotypes in combination with the BSAC disk diffusion
method to examine resistance to chosen CF therapeutics. Previous
studies have shown that there is little correlation between antibiotic
sensitivity patterns of P. aeruginosa isolated during a pulmonary
exacerbation with the clinical response of the patient24,25 and repro-
ducibility of the diagnostic test itself has been shown to be low
between sample replicates26,27.
We have built on this previous work and shown that isolates from
the same patient display considerable variation in susceptibilities
across a broad range of commonly used therapeutics. Pairwise cor-
relation analysis showed that if an individual isolate was resistant to
one antibiotic, it was also likely to be resistant to another.
Correlations in resistance were also found between antibiotics with
similar mechanisms of action. We then mixed all 44 isolates as a
population and repeated the antibiotic susceptibility testing in an
effort to compare the level of antibiotic resistance between individual
isolates and when mixed as a population of isolates. We found that
variation in the zone of inhibition was reduced in mixed versus single
isolates, indicating that picking colonies at random and mixing them
gives a more consistent measure of antibiotic resistance.
Furthermore, we found that mixing all 44 isolates together resulted
in a level of antibiotic resistance that was higher than any individual
isolate tested.
Overall, the literature now highlights the current inadequacies of
performing antibiotic susceptibility tests with single isolates or mor-
photypes to guide clinical decisions regarding antibiotic choice in
chronic P. aeruginosa infections in CF. It suggests that antibiotic
sensitivity testing could be improved by testing multiple colonies
or populations of P. aeruginosa, and that this may lead to better
clinical outcomes in the future. Although ultimately this study pro-
vides detail about the mechanisms of P. aeruginosa evolution in the
CF lung, our findings may also have broader implications for chronic
P. aeruginosa infections in other clinical settings such as non-CF
www.nature.com/scientificreports
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bronchiectasis, chronic obstructive pulmonary disease and burns
patients.
Methods
Bacterial strains and culture conditions. PAO1 was used as a control strain for
phenotypic assays. All clinical isolates were provided in collaboration with
Nottingham University Hospitals NHS Trust. Spontaneous sputum samples were
obtained from a 19 year old female patient with CF, chronically infected with P.
aeruginosa for 3 years. At the time of sampling, the patient was clinical stable and was
prescribed maintenance oral and nebulised therapies only. Sputum samples were
treated with the mucolytic agent SputasolH. Equal volumes of Sputasol (Oxoid) to
sputum were added and incubated at 37uC, 250 rpm for 20–25 minutes until
microcolonies were suitably broken down. Serial dilutions in 900 ml of Phosphate
Buffered Saline (PBS) (Oxoid) were made from a starting concentration of 900 ml PBS
and 100 ml microcolony sample 1021 through to 10210. For each dilution, 100 ml was
plated onto selective Pseudomonas Isolation Agar (PIA) and spread evenly using a
sterile plastic spreader. One duplicate of each concentration per isolate was performed.
For growth, pyocyanin, LasA and LasB assays and QS signal molecule extractions, pre-
cultures grown from a single colony were incubated overnight in liquid Lysogeny
Broth (LB) at 37uC, which were used to inoculate fresh media as described below.
Determination of final growth. Overnight pre-cultures were centrifuged at
10000 rpm for 5 min, then washed and resuspended in 5 ml fresh LB. Growth values
were taken for each isolate (OD600) and used to calculate the inoculation volume for a
starting OD600 of 0.05 in 50 ml LB. Cultures were then incubated with shaking at
37uC for 18 h. Growth was measured by OD600. Cultures were then centrifuged at
10000 rpm for 5 min and 40 ml of supernatant was filter sterilised using 0.2 mM
filters and used for phenotypic analysis.
LasA protease assay. LasA protease activity was determined by assessing the ability of
P. aeruginosa culture supernatants to lyse boiled Staphylococcus aureus cells51.
Overnight cultures of S. aureus (RN6390B) were boiled for 10 min and then
centrifuged at 4000 rpm for 10 min. The resulting pellet was re-suspended in 0.02 M
Tris-HCl (pH 8.5) to an optical density of 0.8 at 600 nm. 190 mL of S. aureus
suspension was added to 8 replicate wells of a 96 well plate (Greiner). 10 mL of filter
sterilised P. aeruginosa supernatant was then added to each well. Optical density at
600 nm (A600) was measured at 10 min intervals for 60 min using a microplate
reader (Tecan InfiniteH 200). LasA activity was determined as the percentage of the
initial A600 value remaining after 60 min.
LasB protease assay. The elastolytic (LasB) activity of P. aeruginosa supernatants was
determined using the elastin Congo red (ECR, Sigma) assay52. A 100 ml aliquot of
filter-sterilized bacterial supernatant was added to 900 ml ECR buffer (100 mM Tris,
1 mM CaCl2, pH 7.5) containing 20 mg ECR and incubated with shaking at 37uC for
3 h at 200 rpm. Insoluble ECR was removed by centrifugation and the absorption of
the supernatant measured at 495 nm. Buffer containing ECR with and without PAO1
supernatant were used as positive and negative controls respectively. The production
of LasB/cell is expressed as the OD495 divided by the final growth (OD600) previously
recorded after 18 h incubation.
Pyocyanin extraction assay. Pyocyanin was extracted and quantified using a
previously described assay53. 3 ml of chloroform was added to 5 ml of sterile
supernatant and vortexed for 2 min. This was then centrifuged at 10000 rpm for
5 min. The bottom chloroform layer was removed and transferred into a new 50 ml
falcon tube to which 2 ml of HCl (0.2 M) was added, mixed and centrifuged. The top
1 ml layer was transferred to a cuvette and the optical density read at 520 nm.
Pyocyanin production for each clinical isolate was measured against PAO1.
QS signal molecule extraction. The method used was based on a previously
described assay for the extraction of QS signal molecules54. A single colony of each
isolate and PAO1 was used to inoculate 10 ml LB and incubated at 37uC at 200 rpm
for 18 h. After incubation, the OD600 was measured for each sample, centrifuged at
13000 rpm for 5 min and 5 ml of supernatant was filter sterilised. 6 ml of acidified
ethyl acetate (0.1% glacial acetic acid) was added to the supernatant, vortexed
thoroughly and centrifuged at 10000 rpm for 5 min. 5 ml from the separated top
layer was transferred into a glass vial. This was repeated a further two times, and
samples pooled into the glass vial after each step. Samples were then dried using a
rotary evaporator. 1.5 ml of methanol was added to dried fractions and transferred to
a 1.5 ml tube. The sample was dried again under nitrogen gas and re-suspended in
250 ml methanol and stored at 280uC until LCMS analysis. LCMS analysis was
performed as previously described54. The method was performed in triplicate for all
44 isolates, PAO1 and appropriate media controls.
Determination of antibiotic susceptibilities using the BSAC method. Bacterial
suspensions were made for each isolate by inoculating 1 ml of sterile distilled water
(SDW) with a single colony in a 1.5 ml sterile tube to a 0.5 McFarland standard and
vortexed gently. Using a sterile cotton swab, each suspension was streaked onto
Isosensitest agar (VWR laboratories) twice to create a bacterial lawn. Antibiotic disks
were then placed onto the agar using a standardised applicator (Oxoid) (Amikacin
30 mg, Ceftazadime 30 mg, Ciprofloxacin 1 mg, Gentamicin 10 mg, Meropenem
10 mg, Pipericillin/Tazobactam (TazocinH) 85 mg, Aztreonam 30 mg, Colistin 25 mg,
Tobramycin 10 mg and Chloramphenicol 10 mg (Oxoid)). Plates were then inverted
and incubated at 37uC for 24 h. The diameter of the zones of inhibition (mm) were
measured and compared to pre-determined breakpoints provided by BSAC, with
each isolate recorded as either sensitive or resistant to each of the chosen
antimicrobials. This experiment was performed in triplicate. All 44 isolates were then
mixed as a population in a 1 ml suspension with SDW. Individual colonies per isolate
were sampled at random from LB agar streaked with glycerol stocks of the chosen
isolate. The population was then diluted to a 0.5 McFarland standard, and the
experiment repeated as previously described 8 times. The Nottingham University
NHS Trust P. aeruginosa control strain (NCTC) was used alongside PAO1 as a
control throughout.
Antibiotic resistance analysis. The mm diameter measurements of clearance zones
were first squared so that values were proportional to the area of the clearance zone.
To obtain a score of resistance the squared clearance zones were mean standardised
within each antibiotic and the negative mean standardised values were taken to be
resistance. In this way we generated antibiotic sensitivity scores that could be
compared across isolates and across antibiotics. Pairwise correlations were performed
using Spearmans rank correlation revealing 12 significantly positively correlated
sensitivity profiles (9 remained significant after correction for multiple testing using
false discovery rate, as described above). Multi-drug resistance was calculated as the
mean resistance score across all antibiotics.
Genome sequencing and analysis. Genomic DNA was prepared from 14 h cultures
of isolates SED1–22. Multiplexed, 150 bp Paired-end sequencing was performed on
the Illumina HiSeq2000 platform to an average of 503 coverage. De novo alignments
were performed using Velvet and the assemblies optimised using the PAGIT suite of
programmes55. Assembled genomes were annotated using Prokka. Comparative
genomics were performed by pairwise Blast analysis using BRIG56 and by Progressive
Mauve genome alignments57. A pan-genome of the population was created using LS-
BSR58 and plotted using ggplot2 in R. Breakpoint analysis using paired end reads was
performed to detect inversions and rearrangements using BreakDancer59, and the
resulting alignments visualised with EasyFig60. Core genome alignments were
performed using Mugsy as previously described61. SNP typing was performed using
SMALT and Samtools against the LESB58 reference genome, with SNPs in IS,
transposons and Phages removed. High fidelity SNPs were then called using a cut off
of minimum allele frequency of 0.75, minimum quality score 30, and minimum depth
of 8 as described previously62. Maximum likelihood phylogenies were created with
RaxML implementing the GTRGamma substitution model, and visualised using
Figtree. Pairwise SNP distance matrices were created using Mega and visualised by
ggplot2 in R. Positive selection on homoplasic SNPs was determined by aligning
genes containing SNPs in Mega, and testing for selection using the codon-based Z test
for selection. All raw sequence data has been deposited to the European Nucleotide
Archive (Accession number: PRJEB5764), and a full set of mapping and assembly
statistics are supplied in Supplementary Table S3.
Statistical association of recombination fragments with phenotypic changes. To
account for the linkage of SNPs and to avoid overly conservative results due to
simplistic multiple testing correction such as the Bonferroni method, we used the
standard approach of permutation association tests, where the isolates are retained
while the phenotypic labels of the individuals are randomly permuted63. The test
procedure for each phenotype was based on 10,000 permutations and the standard
ANOVA test statistic where the null hypothesis of no association is compared to a
general alternative63 using the functions available in the Statistics Toolbox of
MATLAB software (v R2012a). As noted in ref. 23, permutation tests are generally
considered the gold standard in multiple testing adjustment in genetic association
studies, in order to sacrifice as little power as possible, in contrast to for example
Bonferroni type correction. SNPs with the permutation-based p-value , 0.05 were
defined as significantly associated with the phenotype under consideration. The
entire raw data set of p values for each SNP is presented in Supplementary Table S2.
Recombination analysis. The BratNextGen software64 was used to detect
recombination events in the 22 genomes, similar to several recent discoveries made
using this method61,65. The whole-genome alignment produced with Mugsy was used
as input to BratNextGen with the default settings similar to ref. 64 with 20 iterations of
the estimation algorithm. The convergence was assessed to be sufficient since changes
in the hidden Markov model parameters were negligible over approximately the last
50% of the iterations. Significance of each recombining region was determined as in
ref. 64 using a permutation test with 100 permutations executed in parallel on a
cluster computer (threshold of 5% was used to determine significance for each
recombination).
Principal component analysis. Principal component analysis (PCA) was conducted
on QS signal and phenotype data using R 2.14.0 (‘R’ development core team, 2011)
and the FactoMineR package. A single PCA on combined signals 1 virulence factor
data was also performed, but this explained less variation than either of the two
separate analyses; we therefore present the separate analyses as the more
parsimonious approach. Pairwise Spearman’s rank correlations were corrected for
multiple comparisons using a false discovery rate method66.
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